Company registration number 13427880 (England and Wales)
PAIN THERAPY LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
PAGES FOR FILING WITH REGISTRAR
PAIN THERAPY LTD
CONTENTS
Page
Balance sheet
1
Statement of changes in equity
2
Notes to the financial statements
3 - 6
PAIN THERAPY LTD
BALANCE SHEET
AS AT
31 MARCH 2025
31 March 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Intangible assets
-
0
-
0
Tangible assets
3
5,578
14,902
Current assets
Debtors
4
3,498
12,520
Cash at bank and in hand
3,405
311
6,903
12,831
Creditors: amounts falling due within one year
5
(34,265)
(50,484)
Net current liabilities
(27,362)
(37,653)
Net liabilities
(21,784)
(22,751)
Capital and reserves
Called up share capital
100
100
Profit and loss reserves
(21,884)
(22,851)
Total equity
(21,784)
(22,751)

For the financial year ended 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

T he member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved and signed by the director and authorised for issue on 19 February 2026
Mr T Aydin
Director
Company registration number 13427880 (England and Wales)
PAIN THERAPY LTD
STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 MARCH 2025
- 2 -
Share capital
Profit and loss reserves
Total
Notes
£
£
£
Balance at 1 April 2023
100
(24,944)
(24,844)
Year ended 31 March 2024:
Profit and total comprehensive income
-
6,093
6,093
Dividends
-
(4,000)
(4,000)
Balance at 31 March 2024
100
(22,851)
(22,751)
Year ended 31 March 2025:
Profit and total comprehensive income
-
14,952
14,952
Dividends
-
(14,000)
(14,000)
Balance at 31 March 2025
100
(21,884)
(21,784)
PAIN THERAPY LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
- 3 -
1
Accounting policies
Company information

Pain Therapy Ltd is a private company limited by shares incorporated in England and Wales. The registered office is 51 Kenilworth Drive, Oadby, Leicester, LE2 5LT.

1.1
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Revenue

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

1.3
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Plant and equipment
18% Reducing Balance
1.4
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.5
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

PAIN THERAPY LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 4 -
Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future paymen ts discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. A m ounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.6
Taxation

The tax expense represents the sum of the tax currently payable.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

As lessee

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the lease s asset are consumed.

PAIN THERAPY LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 5 -
2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
1
1
3
Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 April 2024
22,759
Disposals
(11,653)
At 31 March 2025
11,106
Depreciation and impairment
At 1 April 2024
7,857
Depreciation charged in the year
2,066
Eliminated in respect of disposals
(4,395)
At 31 March 2025
5,528
Carrying amount
At 31 March 2025
5,578
At 31 March 2024
14,902
4
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
-
0
5,000
Other debtors
3,498
7,520
3,498
12,520
PAIN THERAPY LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 6 -
5
Creditors: amounts falling due within one year
2025
2024
£
£
Corporation tax
5,376
288
Other taxation and social security
100
54
Other creditors
28,789
50,142
34,265
50,484
2025-03-31 2024-04-01 false false false 19 February 2026 CCH Software CCH Accounts Production 2025.300 No description of principal activity Mr T Aydin 13427880 2024-04-01 2025-03-31 13427880 2025-03-31 13427880 2024-03-31 13427880 core:OtherPropertyPlantEquipment 2025-03-31 13427880 core:OtherPropertyPlantEquipment 2024-03-31 13427880 core:CurrentFinancialInstruments core:WithinOneYear 2025-03-31 13427880 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-31 13427880 core:CurrentFinancialInstruments 2025-03-31 13427880 core:CurrentFinancialInstruments 2024-03-31 13427880 core:ShareCapital 2025-03-31 13427880 core:ShareCapital 2024-03-31 13427880 core:RetainedEarningsAccumulatedLosses 2025-03-31 13427880 core:RetainedEarningsAccumulatedLosses 2024-03-31 13427880 core:ShareCapital 2023-03-31 13427880 core:RetainedEarningsAccumulatedLosses 2023-03-31 13427880 bus:Director1 2024-04-01 2025-03-31 13427880 core:RetainedEarningsAccumulatedLosses 2023-04-01 2024-03-31 13427880 2023-04-01 2024-03-31 13427880 core:RetainedEarningsAccumulatedLosses 2024-04-01 2025-03-31 13427880 core:PlantMachinery 2024-04-01 2025-03-31 13427880 core:OtherPropertyPlantEquipment 2024-03-31 13427880 core:OtherPropertyPlantEquipment 2024-04-01 2025-03-31 13427880 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 13427880 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 13427880 bus:FRS102 2024-04-01 2025-03-31 13427880 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 13427880 bus:FullAccounts 2024-04-01 2025-03-31 xbrli:pure xbrli:shares iso4217:GBP